The Global Label-Free Detection (LFD) Market is expected to register a CAGR of 8.5% during the forecast period. The main advantage in LFD techniques is that more direct information can be acquired as the method uses only native proteins and ligands. Innovations in LFD techniques include modification of mass spectrometry to develop surface-enhanced laser desorption/ionization (SELDI) time of flight (TOF)- mass spectrometry (MS) which is an innovative approach that offers on-chip purification of the proteins of interest and subsequent ionization of the retained molecules to be detected. Other innovations in LFD techniques include the modification of surface plasmon resonance (SPR) to develop Localized Surface Plasmon Resonance (LSPR) which provides advantages like lower fabrication costs and higher sensitivity. As per Pfizer Inc, annual report 2019, Pfizer’s expenditures on research and development (R&D) in 2019 was around USD 8.65 billion. This was an increase compared to 2018 which was about USD 8.1 billion. Furthermore, with the introduction of new innovations in the label-free detection technologies the market is expected to experience significant growth.
Key Market Trends
Surface Plasmon Resonance (SPR) Segment is Expected to Hold Largest Share of Global Label-Free Detection (LFD) Market
- Based on technology used, surface plasmon resonance (SPR) technology segment is expected to hold significant market share in the global label-free detection market due to its wide application range and compatibility with a wide range of biomolecules. However, the bio-layer interferometry segment is expected to grow at the fastest rate over the forecast period.
- According to the National Institutes for Health (NIH), total clinical research funding by the National Institutes for Health (NIH) in 2017, 2018 and 2019 was USD 12,695 million, USD 13,870 million, and USD 15,023 million. As clinical research funding increasing which will boost the market in the near future. Furthermore, interferometry provides advantages like less fluctuation in the refractive index of the samples being tested and microfluidic-free nature of bio-layer interferometry label-free detection systems. Hence, owing to above all factors the segment is expected to show growth over the forecast period.
North America Region Holds the Largest Market Share of Label-Free Detection (LFD) Market
North America dominates the global label-free detection market due to technological advancement and high government funding in the region. Also, increasing prevalence of disease and the growth in drug discovery programs in the region. According to the National Clinical Trials Registry (NCT), in 2019, the number of registered clinical studies alone in the United States was around 108,790. Furthermore, partnerships between pharmaceutical companies and academic institutes and the presence of several pharmaceutical and biotechnological companies will also augment the growth of the market.
The Label-Free Detection (LFD) Market is fragmented competitive and consists of several major players. The companies are implementing certain strategic initiatives such as merger, new product launch, acquisition and partnerships that help them in strengthening their market position. Further, these leaders have products for all the end users, a strong grographical presence and also focusing on product innovations.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support